Home > Riviste > Minerva Anestesiologica > Fascicoli precedenti > Minerva Anestesiologica 2015 January;81(1) > Minerva Anestesiologica 2015 January;81(1):52-64

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

MINERVA ANESTESIOLOGICA

Rivista di Anestesia, Rianimazione, Terapia Antalgica e Terapia Intensiva


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,623


eTOC

 

EXPERTS’ OPINION  FREEfree


Minerva Anestesiologica 2015 January;81(1):52-64

Copyright © 2015 EDIZIONI MINERVA MEDICA

lingua: Inglese

Novel multidrug resistant microorganisms in critically ill: a potential threat

Grossi P. A., Tebini A., Dalla Gasperina D.

Infectious and Tropical Diseases Unit, Department of Surgical and Morphological Sciences, Ospedale di Circolo e Fondazione Macchi, University of Insubria, Varese, Italy


FULL TEXT  


Infections due to multidrug resistant (MDR) pathogens are among the major threats in critically ill patients. Reduced vancomycin susceptibility in Staphylococcus aureus, high-level aminoglycoside resistance in enterococci, extended spectrum beta-lactamase and carbapenemases production in Enterobacteriaceae, carbapenem and colistin resistance in Pseudomonas spp. and Acinetobacter spp. are increasing in many intensive care units around the world. In the last few years some new anti-Gram-positive agents have been developed, whereas for Gram-negatives the available options are very limited. Infections control and antimicrobial stewardship programs are currently the only available options to avoid a further increase of these pathogens.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

paolo.grossi@uninsubria.it